These continuation studies focus on a large pancreas transplant (PT) population of insulin dependent diabetic (IDDM) patients (pts) in order to better understand diabetic nephropathy (DN), the leading cause of renal failure. Objectives are: (a) to determine whether PT can arrest or reverse the early or the more established lesions of DN, (b) describe the nature of and the message (MRNA) for the extracellular matrix (ECM) molecules which accumulate to produce DN, (c) to evaluate renal structural risk factors for DN, and (d) to describe the structural and functional nephrotoxicity of immunosuppression drugs [Cyclosporin (CSA) and Tacrolimus (FK506)] used in PT. Pts include those with long IDDM duration and established DN lesions undergoing PT alone (PTA), and for the study of early DN lesions, IDDM pts with PT performed a few years after kidney transplant (PAK). We will evaluate the effects of PT on the early and late DN lesions by comparing baseline with 5, 10, and 15 year postPT renal biopsies (bx). Controls will include IDDM pts not undergoing PT with bx at parallel times of native or transplanted kidneys. We will also determine from these controls if DN lesions develop at linear rates and where different lesions develop at different rates. We will study whether glomerular number (GN) is a risk factor for DN in native kidneys by estimating GN from prePT renal bx and ultrasound studies. ECM dynamics will be studied by immunofluorescence microscopy and quantitative immunogold EM immunochemistry and by in situ hybridization. We will evaluate the relationship of dose, blood levels, and duration of CSA and FK506 therapy to nephrotoxicity by morphometric measure of interstitial and glomerular scarring in PTA recipients.

Project Start
2001-12-01
Project End
2002-11-30
Budget Start
Budget End
Support Year
34
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Berglund, Danielle M; Zhang, Lei; Matas, Arthur J et al. (2018) Measured Glomerular Filtration Rate After Kidney Donation: No Evidence of Accelerated Decay. Transplantation 102:1756-1761
Matas, Arthur J; Vock, David M; Ibrahim, Hassan N (2018) GFR ?25 years postdonation in living kidney donors with (vs. without) a first-degree relative with ESRD. Am J Transplant 18:625-631
Sanchez, Otto A; Ferrara, Laine K; Rein, Sarah et al. (2018) Hypertension after kidney donation: Incidence, predictors, and correlates. Am J Transplant 18:2534-2543
Kizilbash, Sarah J; Rheault, Michelle N; Bangdiwala, Ananta et al. (2017) Infection rates in tacrolimus versus cyclosporine-treated pediatric kidney transplant recipients on a rapid discontinuation of prednisone protocol: 1-year analysis. Pediatr Transplant 21:
Verghese, P S; Schmeling, D O; Filtz, E A et al. (2017) The impact of recipient BKV shedding before transplant on BKV viruria, DNAemia, and nephropathy post-transplant: A prospective study. Pediatr Transplant 21:
Serrano, Oscar Kenneth; Kandaswamy, Raja; Gillingham, Kristen et al. (2017) Rapid Discontinuation of Prednisone in Kidney Transplant Recipients: 15-Year Outcomes From the University of Minnesota. Transplantation 101:2590-2598
Ibrahim, H N; Berglund, D M; Jackson, S et al. (2017) Renal Consequences of Diabetes After Kidney Donation. Am J Transplant 17:3141-3148
Gross, Cynthia R; Reilly-Spong, Maryanne; Park, Taehwan et al. (2017) Telephone-adapted Mindfulness-based Stress Reduction (tMBSR) for patients awaiting kidney transplantation. Contemp Clin Trials 57:37-43
Ibrahim, Hassan N; Foley, Robert N; Reule, Scott A et al. (2016) Renal Function Profile in White Kidney Donors: The First 4 Decades. J Am Soc Nephrol 27:2885-93
Verghese, Priya; Gillingham, Kristen; Matas, Arthur et al. (2016) Post-transplant blood transfusions and pediatric renal allograft outcomes. Pediatr Transplant 20:939-945

Showing the most recent 10 out of 356 publications